AzTrials
AzTrials

Critically IllNCT02286869

Cardioventilatory Coupling in Critically Ill Patients

A study testing Three different mechanical ventilation modes in people with Critically Ill, run by ASST Fatebenefratelli Sacco at 2 sites in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study measures the cardioventilatory coupling in critically ill patients during mechanical ventilation in controlled mode (pressure controlled) and in patient-driven mode (pressure support and neurally adjusted ventilatory assist). Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Critically Ill
What is being tested?
Three different mechanical ventilation modes
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
22 participants
Where
2 sitesItaly
Study dates
Sep 2016to Jul 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • patients consecutively admitted to the mixed intensive care unit of the Luigi Sacco Hospital with (all the following):
  • mechanical ventilation with an expected duration ≥ 48 hours
  • acute respiratory failure due to ALI/ARDS or COPD exacerbation or pneumonia or severe sepsis/septic shock
  • age between 18 and 75 years old

Who cannot join

  • contraindications to esophageal tube positioning (i.e. esophageal varices, bleeding from upper enteric tract in the past 30 days)
  • history of esophageal or gastric or thoracic surgery
  • history of neuromuscular disease or stroke or head trauma
  • history of thyroidal or adrenal dysfunction
  • positive end expiratory pressure ≥ 10 cmH2O and/or inspiratory oxygen fraction ≥ 0.60, or intrinsic positive end expiratory pressure ≥ 8 cmH2O
  • needing for neuromuscular blocking drugs administration
Show all 14Show fewer
  • patients unable to undergo to patient-driven mechanical ventilation mode (i.e. coma, excessive sedation)
  • mechanical circulatory support (i.e. intra-aortic balloon, extracorporeal membrane oxygenation)
  • norepinephrine ≥0.3 mcg/kg/min or epinephrine ≥0.05 mcg/kg/min or dobutamine ≥2.5 mcg/kg/min
  • non sinus cardiac rhythm or ectopic beats exceeding ≥5% of normal sinus beats
  • acute or chronic heart failure with reduced or preserved ejection fraction
  • recent acute miocardial infarct ≤6 months
  • recent recovery from respiratory failure or pneumonia or severe sepsis/septic shock ≤30 days
  • therapy with beta-blockers

Trial locations and contacts

2 sites in 1 country.

Italy2 sites
  • Luigi Sacco Hospital

    Milan, 20157

  • Istituto Clinico Humanitas

    Rozzano, 20089

Other trials in Italy

About this study

This study measures the cardioventilatory coupling in critically ill patients during mechanical ventilation in controlled mode (pressure controlled) and in patient-driven mode (pressure support and neurally adjusted ventilatory assist).

Read the detailed description

Intrathoracic pressure oscillations due to positive pressure ventilation induce cyclic modifications of activity of the pulmonary vascular receptors and cardiac mechanoceptors. These effects changes the autonomic nervous system modulation with modification of both sympathetic and vagal activity.

Cardio-ventilatory interaction recently has been studied through the heart rate variability in critically ill mechanical ventilated patients. The analysis of the power spectrum density provides information about the power (the variance of beat-to-beat interval) is distributed as frequencies' function. Healthy spontaneously breathing subjects show a cyclic inspiratory increase and expiratory decrease of heart rate, and 'phase coupling' between heart beats and respiration (causing heart beats to occur at constant phases of the respiratory cycle), commonly known as cardioventilatory coupling. These phenomena originate from a complex interplay of several mechanisms including central drive, feedback from arterial baroreceptors, feedback from thoracic and lung stretch receptors, and non-neural mechanisms intrinsic to the heart, which are not fully understood. Although the physiological importance of respiratory sinus arrhythmia and cardioventilatory coupling have not been elucidated, several authors suggested that they might improve ventilation/perfusion matching through a redistribution of heart beats (and consequently of perfusion) within the respiratory cycle, with beneficial effects on gas exchange. Furthermore, decreased respiratory sinus arrhythmia amplitude has been used as an indicator of impaired autonomic control and of poor clinical outcome, also during mechanical ventilation.It has been shown that during controlled mechanical ventilation the respiratory sinus arrhythmia amplitude is considerably reduced and the cardioventilatory coupling generally abolished. Theoretically, mechanical ventilation modes that assist the respiratory pump upon triggering by the patient, such as pressure support ventilation (PSV) might maintain higher respiratory sinus arrhythmia levels through centrally-originated phasic vagal modulation compared to controlled mechanical ventilation. In addition, mechanical ventilation with breath-by-breath variable tidal volumes, so-called 'variable ventilation', could better preserve respiratory sinus arrhythmia and cardioventilatory coupling, and this might play a role in the improved arterial oxygenation found in different models of acute lung injury, although with variable results, when comparing variable and conventional mechanical ventilation. In anesthetized experimental animals the cardioventilatory coupling was more preserved during pressure assisted ventilation than pressure controlled ventilation. If these findings could be present in the humans is yet unknown. Furthermore, it has been demonstrated that some new methodologies of assisted ventilation, such as the neurally adjusted ventilatory assist (NAVA), increase the breath-to-breath variability and tidal volume variability, but their effects on cardioventilatory coupling are not understood.

The study aims to measure the heart rate variability, the respiratory rate variability and the cardioventilatory coupling in critically ill patients during mechanical ventilation both in controlled mode (pressure controlled) and in assisted mode (pressure support ventilation and NAVA).

Methods enrolled patients are connected to a S/5 ICU monitor (GE, Helsinki, Finland) and are mechanically ventilated with a Servo-I ventilator (Maquet, Germany) provided with diaphragmatic electrical activity module (EAdi, Maquet, Germany). A nasogastric 16-Fr EAdi catheter is positioned in all patients. A sequence of three consecutive study phases of different mechanical ventilation modes (PCV, PSV, and NAVA) is started. The sequence of ventilatory modes is randomized for every patient. After a 10 min acclimation period for each study phase, electrocardiographic, arterial pressure and ventilatory waves are collected for consecutive 30 min to a laptop pc via S/5 Collect (GE, Helsinki, Finland) and NAVA Tracker (Maquet, Germany) software for Windows.

Heart rate variability analysis Linear analysis Sequences of 300 consecutives heart beats are selected inside each experimental phase. The mean and the variance of heart period are expressed in msec and msec^2 respectively. Autoregressive spectral density is factorized into components each of them characterized by a central frequency. A spectral component is labeled as LF if its central frequency is between 0.04 and 0.15 Hz, while it is classified as HF if its central frequency is between 0.15 and 0.5 Hz. The HF power is considered to represent respiration-driven vagal modulation of heart rate. To rule out the effect of changes of total power spectrum densities on LF and HF components, spectral values are also expressed in normalized units (NU). Normalization consisted in dividing the power of a given spectral component by the total power minus the power below 0.04 Hz (Very Low Frequency [VLF] spectral component), and multiplying the ratio by 100. The ratio of the LF power to the HF (LF/HF) is considered an indicator of the balance between sympathetic and vagal modulation directed to the heart.

Nonlinear analysis Non-linear analysis was conducted by means of symbolic analysis. The symbolic analysis is conducted on the same sequences of 300 consecutive heart beats that are used for the autoregressive analysis. The whole range of the R-to-R interval into each series is uniformly divided in 6 slices (symbols) and pattern of 3 consecutive heart beat intervals were considered. Thus each sequence of 300 heart beats had its own R-to-R range and 298 consecutive triplets of symbols. The Shannon entropy of the distribution of the patterns is calculated to provide a quantification of the complexity of the pattern distribution. All triplets of symbols are grouped into 3 possible patterns of variation: (i) no variation (0V, all 3 symbols were equal), (ii) 1 variation (1V, 2 consequent symbols were equal and the remaining symbol was different), (iii) patterns with 2 variations (2V, all symbols were different from the previous one). Previously, the percentage of 0V patterns was found to increase (and 2V decrease) in response to sympathetic stimuli, whereas 2V patterns increased (and 0V decreased) in response to vagal stimuli. The percentage of the patterns 0V and 2V was calculated, and the 0V/2V ratio was calculated to estimate the balance between sympathetic and vagal modulation.

Cardioventilatory coupling analysis Phase synchronization method for quantification of coupling between weakly coupled self-sustained oscillators (here heart and ventilator) will be implemented. The idea behind is that a good ventilatory mode should produce cardio-respiratory coordination indistinguishable from that observed in healthy subject during spontaneous breathing at the same frequency and amplitude. Phase synchronization technique is complemented with joint symbolic analysis and cross-conditional entropy assessing of cardio-respiratory coupling in terms of degree of repeatability of coordination schemes between heart rate signal and ventilation. These approaches have the main advantages that they are less sensitive to non-stationarities and they are capable of capturing nonlinear couplings over shorter data sequences.

Sample size given a heart rate variability total variance equal to 1000 msec^2, to detect a difference of 300 msec^2 (with a standard deviation of 200 msec^2) between the study phases with an alpha error=0.05, power=80%, effect size=0.4, 22 patients will be recruited.

The normal distribution is checked with Kolmogorov-Smirnov test. Two tails Student t test for dependent or independent sample as needed, or Wilcoxon- U test in case of not normal distribution are employed. Repeated measures are analyzed with one way analysis of variance (ANOVA) followed by post-hoc Bonferroni's test.

Conditions
Critically Ill
Being tested
Three different mechanical ventilation modes
Keywords
mechanical ventilation, autonomic nervous system, heart rate variability, cardioventilatory coupling
Medical subject headings
Critical Illness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Three different mechanical ventilation modesProcedure or surgery

    patients are randomly assigned to every arm. Baseline is the period immediatly before the study phase. The study phase is the sequence of three consecutive trials of different modes of mechanical ventilation. Every trial lasts 30 min plus 10 min of acclimation.

Study groups in NCT02286869
Study groupRoleWhat they receive
Pressure Controlled VentilationExperimentalINTERVENTION: respiratory trial in pressure controlled mode: (i) the inspiratory pressure is set up to obtain the same tidal volume than baseline, (ii) the imposed respiratory rate is the same respiratory rate than baseline. The positive end expiratory pressure and fractional inspiratory oxygen are unchanged from the baseline. After an acclimation period of 10 min, electrocardiographic, arterial pressure and respiratory waves are recorded for 30 min.
Receives: Procedure: Three different mechanical ventilation modes
Pressure Support VentilationExperimentalINTERVENTION: respiratory trial in pressure support mode: (i) the inspiratory pressure is set up to obtain the same tidal volume than baseline, (ii) the inspiratory trigger is a flow-trigger with medium sensitivity. The positive end expiratory pressure and fractional inspiratory oxygen are unchanged from the baseline. In this ventilatory mode the respiratory rate is not imposed because is driven by the patient's respiratory effort. After an acclimation period of 10 min, electrocardiographic, arterial pressure and respiratory waves are recorded for 30 min.
Receives: Procedure: Three different mechanical ventilation modes
Neurally Adjusted Ventilatory AssistExperimentalINTERVENTION: respiratory trial in Neurally Adjusted Ventilatory Assist (NAVA) mode: (i) NAVA-level (gain) is set up to obtain the same tidal volume than baseline, (ii) the inspiratory trigger is a neural trigger set at 0.5 microVolt. The positive end expiratory pressure and fractional inspiratory oxygen are unchanged from the baseline. In this ventilatory mode the respiratory rate is not imposed because is driven by the patient's respiratory effort. After an acclimation period of 10 min, electrocardiographic, arterial pressure and respiratory waves are recorded for 30 min.
Receives: Procedure: Three different mechanical ventilation modes

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. to measure the cardioventilatory coupling in mechanically ventilated critically ill patients during three different mechanical ventilation settings

    to measure the cardioventilatory coupling in mechanically ventilated critically ill patients during three different modes of mechanical ventilation: (i) Pressure Controlled Ventilation, (ii)

    Measured: 120 min

Secondary outcomes (1)
  1. to measure the heart rate variability in mechanically ventilated critically ill patients during three different mechanical ventilation settings

    to measure the heart rate variability in mechanically ventilated critically ill patients during three different modes of mechanical ventilation: (i) Pressure Controlled Ventilation, (ii)

    Measured: 120 min

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Nov 2014 (estimated)
  2. Study startSep 2016
  3. Primary completionMar 2017
  4. Study completionJul 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
22 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02286869
Sponsor's protocol ID
CaVeCo
Status last verified
Jul 2017
First submitted
4 Nov 2014
Last updated
1 Aug 2017
Results posted
No
Data monitoring committee
No

Publications

  • Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, Sandrone G, Malfatto G, Dell'Orto S, Piccaluga E, et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res. 1986 Aug;59(2):178-93. doi: 10.1161/01.res.59.2.178.

    PubMed 2874900
  • Nollo G, Faes L, Porta A, Antolini R, Ravelli F. Exploring directionality in spontaneous heart period and systolic pressure variability interactions in humans: implications in the evaluation of baroreflex gain. Am J Physiol Heart Circ Physiol. 2005 Apr;288(4):H1777-85. doi: 10.1152/ajpheart.00594.2004. Epub 2004 Dec 16.

    PubMed 15604132
  • Rosenblum MG, Cimponeriu L, Bezerianos A, Patzak A, Mrowka R. Identification of coupling direction: application to cardiorespiratory interaction. Phys Rev E Stat Nonlin Soft Matter Phys. 2002 Apr;65(4 Pt 1):041909. doi: 10.1103/PhysRevE.65.041909. Epub 2002 Mar 28.

    PubMed 12005875
  • Porta A, Baselli G, Lombardi F, Montano N, Malliani A, Cerutti S. Conditional entropy approach for the evaluation of the coupling strength. Biol Cybern. 1999 Aug;81(2):119-29. doi: 10.1007/s004220050549.

    PubMed 10481240
  • Porta A, Guzzetti S, Montano N, Furlan R, Pagani M, Malliani A, Cerutti S. Entropy, entropy rate, and pattern classification as tools to typify complexity in short heart period variability series. IEEE Trans Biomed Eng. 2001 Nov;48(11):1282-91. doi: 10.1109/10.959324.

    PubMed 11686627
  • Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996 Mar 1;93(5):1043-65. No abstract available.

    PubMed 8598068
  • Galletly DC, Larsen PD. Inspiratory timing during anaesthesia: a model of cardioventilatory coupling. Br J Anaesth. 2001 Jun;86(6):777-88. doi: 10.1093/bja/86.6.777.

    PubMed 11573583
  • Giardino ND, Glenny RW, Borson S, Chan L. Respiratory sinus arrhythmia is associated with efficiency of pulmonary gas exchange in healthy humans. Am J Physiol Heart Circ Physiol. 2003 May;284(5):H1585-91. doi: 10.1152/ajpheart.00893.2002. Epub 2003 Jan 23.

    PubMed 12543637
  • Hayano J, Yasuma F, Okada A, Mukai S, Fujinami T. Respiratory sinus arrhythmia. A phenomenon improving pulmonary gas exchange and circulatory efficiency. Circulation. 1996 Aug 15;94(4):842-7. doi: 10.1161/01.cir.94.4.842.

    PubMed 8772709
  • Schmidt M, Demoule A, Cracco C, Gharbi A, Fiamma MN, Straus C, Duguet A, Gottfried SB, Similowski T. Neurally adjusted ventilatory assist increases respiratory variability and complexity in acute respiratory failure. Anesthesiology. 2010 Mar;112(3):670-81. doi: 10.1097/ALN.0b013e3181cea375.

    PubMed 20179505
  • Guzzetti S, Borroni E, Garbelli PE, Ceriani E, Della Bella P, Montano N, Cogliati C, Somers VK, Malliani A, Porta A. Symbolic dynamics of heart rate variability: a probe to investigate cardiac autonomic modulation. Circulation. 2005 Jul 26;112(4):465-70. doi: 10.1161/CIRCULATIONAHA.104.518449. Epub 2005 Jul 18.

    PubMed 16027252

Questions about this trial

What is this clinical trial studying?

A study testing Three different mechanical ventilation modes in people with Critically Ill, run by ASST Fatebenefratelli Sacco at 2 sites in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Aug 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

to measure the cardioventilatory coupling in mechanically ventilated critically ill patients during three different mechanical ventilation settings (time frame: 120 min). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02286869, which also lists 11 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Aug 2017; AzTrials last refreshed its copy on 30 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in